Paper797495
Drug dosage in renal disease.
Dettli L. Clin Pharmacokinet, 1976. Cited by 91 papers, by iCite.
11 sourcespapers-2026-11-12-0.1.0
Cite this record
ConductScience Library. Drug dosage in renal disease. Papers, record 797495. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/797495
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics9
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Kidney Diseases | Major topic |
| Pharmaceutical Preparations | Major topic |
| Creatinine | |
| Drug Administration Schedule | |
| Humans | |
| Kinetics | |
| Mathematics | |
| Metabolic Clearance Rate | |
| Models, Biological |
Source PubMed
References22
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 5,415,142 | Antimicrobial therapy in patients with renal insufficiency. | Postgrad Med | 1970 | https://conductscience.org/library/papers/5415142 | PubMed |
| 2 | 4,378,402 | Protein binding of diphenylhydantoin and desmethylimipramine in plasma from patients with poor renal function. | N Engl J Med | 1971 | https://conductscience.org/library/papers/4378402 | PubMed |
| 3 | 5,046,120 | Drug elimination and apparent volume of distribution in multicompartment systems. | J Pharm Sci | 1972 | https://conductscience.org/library/papers/5046120 | PubMed |
| 4 | 5,819,419 | Correlation of serum creatinine concentration and kanamycin half-life. Therapeutic implications. | JAMA | 1969 | https://conductscience.org/library/papers/5819419 | PubMed |
| 5 | 1,150,365 | Calculation of drug dosage regimens in patients with renal disease: a new nomographic method. | Int J Clin Pharmacol Biopharm | 1975 | https://conductscience.org/library/papers/1150365 | PubMed |
| 6 | 4,359,016 | Pharmacokinetics and dosing of antimicrobial agents in renal impairment. I. | Am J Hosp Pharm | 1974 | https://conductscience.org/library/papers/4359016 | PubMed |
| 7 | 5,536,348 | A practical guide to drug usage in adult patients with impaired renal function. | JAMA | 1970 | https://conductscience.org/library/papers/5536348 | PubMed |
| 8 | 4,822,591 | Relevant pharmacokinetics of antimicrobial drugs. | Med Clin North Am | 1974 | https://conductscience.org/library/papers/4822591 | PubMed |
| 9 | 4,102,655 | Rapid evaluation of creatinine clearance. | Lancet | 1971 | https://conductscience.org/library/papers/4102655 | PubMed |
| 10 | 4,425,338 | Individualization of drug dosage in patients with renal disease. | Med Clin North Am | 1974 | https://conductscience.org/library/papers/4425338 | PubMed |
| 11 | 1,149,366 | Digoxin pharmacokinetics: role of renal failure in dosage regimen design. | Clin Pharmacol Ther | 1975 | https://conductscience.org/library/papers/1149366 | PubMed |
| 12 | 1,153,839 | A new simple and rapid method to monitor the renal function based on pharmacokinetic consideration of endogeneous creatinine=. | Res Commun Chem Pathol Pharmacol | 1975 | https://conductscience.org/library/papers/1153839 | PubMed |
| 13 | 5,010,514 | [How to prescribe drugs in the presence of functional renal deficiencies. Tables of dosage adjustment]. | Schweiz Med Wochenschr | 1972 | https://conductscience.org/library/papers/5010514 | PubMed |
| 14 | 4,821,438 | Pharmacokinetics of cefazolin in normal and uremic subjects. | Clin Pharmacol Ther | 1974 | https://conductscience.org/library/papers/4821438 | PubMed |
| 15 | 4,843,318 | Drug dosage in patients with renal disease. | Clin Pharmacol Ther | 1974 | https://conductscience.org/library/papers/4843318 | PubMed |
| 16 | 13,804,370 | The pathologic physiology of chronic Bright's disease. An exposition of the "intact nephron hypothesis". | Am J Med | 1960 | https://conductscience.org/library/papers/13804370 | PubMed |
| 17 | 6,028,645 | A guide to use of antibiotics in patients with renal disease. A table of recommended doses and factors governing serum levels. | Ann Intern Med | 1967 | https://conductscience.org/library/papers/6028645 | PubMed |
| 18 | 5,488,205 | Drug dosage in patients with impaired renal function. | Postgrad Med J | 1970 | https://conductscience.org/library/papers/5488205 | PubMed |
| 19 | 1,149,362 | Decreased plasma protein binding of diazoxide in uremia. | Clin Pharmacol Ther | 1975 | https://conductscience.org/library/papers/1149362 | PubMed |
| 20 | 1,149,361 | Prediction of drug dosage in patients with renal failure using data derived from normal subjects. | Clin Pharmacol Ther | 1975 | https://conductscience.org/library/papers/1149361 | PubMed |
Cited by57
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 91 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42,426,424 | Physiologically based pharmacokinetic modeling of cefotaxime to inform pediatric dosing in renal impairment. | Eur J Clin Pharmacol | 2026 | https://conductscience.org/library/papers/42426424 | PubMed |
| 39,821,536 | Dosage Optimization Using Physiologically Based Pharmacokinetic Modeling for Pediatric Patients with Renal Impairment: A Case Study of Meropenem. | AAPS PharmSciTech | 2025 | https://conductscience.org/library/papers/39821536 | PubMed |
| 35,508,593 | Determining the Effects of Chronic Kidney Disease on Organic Anion Transporter1/3 Activity Through Physiologically Based Pharmacokinetic Modeling. | Clin Pharmacokinet | 2022 | https://conductscience.org/library/papers/35508593 | PubMed |
| 34,725,352 | Bridging the gap between in silico and in vivo by modeling opioid disposition in a kidney proximal tubule microphysiological system. | Sci Rep | 2021 | https://conductscience.org/library/papers/34725352 | PubMed |
| 31,375,913 | Pharmacokinetics in children with chronic kidney disease. | Pediatr Nephrol | 2020 | https://conductscience.org/library/papers/31375913 | PubMed |
| 29,546,450 | [Dose adjustment of anti-infective drugs in patients with renal failure and renal replacement therapy in intensive care medicine : Recommendations from the renal section of the DGIIN, ÖGIAIN and DIVI]. | Med Klin Intensivmed Notfmed | 2018 | https://conductscience.org/library/papers/29546450 | PubMed |
| 29,029,541 | Cancer and the kidney: dangereoux liasons or price paid for the progress in medicine? | Oncotarget | 2017 | https://conductscience.org/library/papers/29029541 | PubMed |
| 28,675,584 | Does Secretory Clearance Follow Glomerular Filtration Rate in Chronic Kidney Diseases? Reconsidering the Intact Nephron Hypothesis. | Clin Transl Sci | 2017 | https://conductscience.org/library/papers/28675584 | PubMed |
| 26,150,141 | Development of a computerised decisions support system for renal risk drugs targeting primary healthcare. | BMJ Open | 2015 | https://conductscience.org/library/papers/26150141 | PubMed |
| 26,017,400 | Suboptimal antimicrobial drug exposure in patients with renal impairment. | Int J Clin Pharm | 2015 | https://conductscience.org/library/papers/26017400 | PubMed |
| 25,855,244 | A Synopsis of Clinical Pharmacokinetic Alterations in Advanced CKD. | Semin Dial | 2015 | https://conductscience.org/library/papers/25855244 | PubMed |
| 25,812,546 | [Antibiotic dosing for renal function disorders and continuous renal replacement therapy]. | Anaesthesist | 2015 | https://conductscience.org/library/papers/25812546 | PubMed |
| 22,695,895 | [Pharmacotherapy in patients suffering from chronic kidney disease]. | Internist (Berl) | 2012 | https://conductscience.org/library/papers/22695895 | PubMed |
| 22,242,561 | Pharmacokinetic predictions for patients with renal impairment: focus on peptides and protein drugs. | Br J Clin Pharmacol | 2012 | https://conductscience.org/library/papers/22242561 | PubMed |
| 20,959,896 | Drug therapy in patients with chronic renal failure. | Dtsch Arztebl Int | 2010 | https://conductscience.org/library/papers/20959896 | PubMed |
| 20,683,672 | [Questionnaire surveying nephrologists on drug dose adjustment in patients with impaired kidney function]. | Wien Klin Wochenschr | 2010 | https://conductscience.org/library/papers/20683672 | PubMed |
| 16,247,710 | Pharmacokinetic significance of renal OAT3 (SLC22A8) for anionic drug elimination in patients with mesangial proliferative glomerulonephritis. | Pharm Res | 2005 | https://conductscience.org/library/papers/16247710 | PubMed |
| 14,984,259 | Expression levels of renal organic anion transporters (OATs) and their correlation with anionic drug excretion in patients with renal diseases. | Pharm Res | 2004 | https://conductscience.org/library/papers/14984259 | PubMed |
| 12,463,936 | Understanding usage patterns of handheld computers in clinical practice. | Proc AMIA Symp | 2002 | https://conductscience.org/library/papers/12463936 | PubMed |
| 11,708,763 | Pregnancy and renal failure: the case for application of dosage guidelines. | Drugs | 2001 | https://conductscience.org/library/papers/11708763 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/797495
GET https://conductscience.org/api/papers/v1/797495/references?page=2